Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT‐AF

BACKGROUND: Chronic kidney disease (CKD) is a common comorbidity in patients with atrial fibrillation. The presence of CKD complicates drug selection for stroke prevention and rhythm control. METHODS AND RESULTS: Patients enrolled in ORBIT AF (Outcomes Registry for Better Informed Treatment of Atria...

Descripción completa

Detalles Bibliográficos
Autores principales: Washam, Jeffrey B., Holmes, DaJuanicia N., Thomas, Laine E., Pokorney, Sean D., Hylek, Elaine M., Fonarow, Gregg C., Mahaffey, Kenneth W., Gersh, Bernard J., Kowey, Peter R., Ansell, Jack E., Go, Alan S., Reiffel, James A., Freeman, James V., Singer, Daniel E., Naccarelli, Gerald, Blanco, Rosalia, Peterson, Eric D., Piccini, Jonathan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222961/
https://www.ncbi.nlm.nih.gov/pubmed/30371218
http://dx.doi.org/10.1161/JAHA.118.008928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222961/
https://www.ncbi.nlm.nih.gov/pubmed/30371218
http://dx.doi.org/10.1161/JAHA.118.008928

Ejemplares similares